Weidong Chen

Zhongshan, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Incomplete Intestinal Metaplasia as a High-Risk Clinical Phenotype in Gastric Carcinogenesis: Implications for Surveillance and Management.

Incomplete Intestinal Metaplasia as a High-Risk Clinical Phenotype in Gastric Carcinogenesis: Implications for Surveillance and Management.

Journal: Digestion

Published: February 03, 2026

Induction Chemotherapy Followed by Immunotherapy Increases Pathological Complete Response Rate in dMMR/MSI-H Gastric Cancer: A Retrospective Cohort Study.

Induction Chemotherapy Followed by Immunotherapy Increases Pathological Complete Response Rate in dMMR/MSI-H Gastric Cancer: A Retrospective Cohort Study.

Journal: ImmunoTargets and therapy

Published: August 31, 2025

Circulating tumor DNA analysis for prediction of prognosis and molecular insights in patients with resectable gastric cancer: results from a prospective study.

Circulating tumor DNA analysis for prediction of prognosis and molecular insights in patients with resectable gastric cancer: results from a prospective study.

Journal: MedComm

Published: June 02, 2024

Targeting ZFP64/GAL-1 axis promotes therapeutic effect of nab-paclitaxel and reverses immunosuppressive microenvironment in gastric cancer.

Targeting ZFP64/GAL-1 axis promotes therapeutic effect of nab-paclitaxel and reverses immunosuppressive microenvironment in gastric cancer.

Journal: Journal of experimental & clinical cancer research : CR

Published: August 30, 2021

Tumor size and perineural invasion predict outcome of gastric high-grade neuroendocrine neoplasms.

Tumor size and perineural invasion predict outcome of gastric high-grade neuroendocrine neoplasms.

Journal: Endocrine connections

Published: June 22, 2021

Oxaliplatin plus Capecitabine in the Perioperative Treatment of Locally Advanced Gastric Adenocarcinoma in Combination with D2 Gastrectomy: NEO-CLASSIC Study.

Oxaliplatin plus Capecitabine in the Perioperative Treatment of Locally Advanced Gastric Adenocarcinoma in Combination with D2 Gastrectomy: NEO-CLASSIC Study.

Journal: The oncologist

Published: March 03, 2019

Asparaginyl endopeptidase improves the resistance of microtubule-targeting drugs in gastric cancer through IQGAP1 modulating the EGFR/JNK/ERK signaling pathway.

Asparaginyl endopeptidase improves the resistance of microtubule-targeting drugs in gastric cancer through IQGAP1 modulating the EGFR/JNK/ERK signaling pathway.

Journal: OncoTargets and therapy

Published: February 23, 2017

Establishment of risk evaluation model of peritoneal metastasis in gastric cancer and its predictive value

Establishment of risk evaluation model of peritoneal metastasis in gastric cancer and its predictive value

Journal: Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery

Published: January 21, 2017

The IGCA staging system is more accurate than AJCC7 system in stratifying survival of patients with gastric cancer in stage III.

The IGCA staging system is more accurate than AJCC7 system in stratifying survival of patients with gastric cancer in stage III.

Journal: BMC cancer

Published: December 06, 2016

Expanded endoscopic therapy criteria should be cautiously used in intramucosal gastric cancer.

Expanded endoscopic therapy criteria should be cautiously used in intramucosal gastric cancer.

Journal: Chinese journal of cancer research = Chung-kuo yen cheng yen chiu

Published: August 02, 2016

Loss of RACK1 Promotes Metastasis of Gastric Cancer by Inducing a miR-302c/IL8 Signaling Loop.

Loss of RACK1 Promotes Metastasis of Gastric Cancer by Inducing a miR-302c/IL8 Signaling Loop.

Journal: Cancer research

Published: December 16, 2014

A concordant expression pattern of fatty acid synthase and membranous human epidermal growth factor receptor 2 exists in gastric cancer and is associated with a poor prognosis in gastric adenocarcinoma patients.

A concordant expression pattern of fatty acid synthase and membranous human epidermal growth factor receptor 2 exists in gastric cancer and is associated with a poor prognosis in gastric adenocarcinoma patients.

Journal: Oncology letters

Published: August 15, 2014

Showing 1-12 of 16

Last Updated: 09/26/2026